C.r. Bard, Inc.

Franklin Lakes, NJ Part of Becton, Dickinson And Co

UEI
YG4KJNJEK3U4
CAGE
13120
Primary NAICS
334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, Becton, Dickinson and Co, ranks:

and 32 more

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
Howe Buidling, 1 Becton Dr, Franklin Lakes, NJ 07417, USA
Website
crbard.com
Founded
1907
Employees
10K-50K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $154,915
FY2025 $243,797
FY2024 $224,666
FY2023 $167,710

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $154,915

Contract vehicles

Contract awards

Award Agency Obligated Awarded
Vascular stents 36C25526P0272 Veterans Integrated Service Network 15 (VHA) $17,085
Pre surgery 36C26326P0590 Veterans Integrated Service Network 23 (VHA) $27,690
Pre-surgery 36C26326P0510 Veterans Integrated Service Network 23 (VHA) $31,800
Covera covered stent 36C25526P0216 Veterans Integrated Service Network 15 (VHA) $18,732
Covera stent 36C25526P0109 Veterans Integrated Service Network 15 (VHA) $18,732

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

C.R. Bard, Inc., doing business as Bard, a subsidiary of Becton, Dickinson and Company, supplies vascular stents, surgical implants, mesh, catheters, and prosthetic devices to the Department of Veterans Affairs and the Defense Health Agency as a prime contractor competing under full and open (no set-aside) procurement. Bard operates from Franklin Lakes, New Jersey, and manufactures medical devices under primary NAICS 334510 (Surgical and Medical Instrument Manufacturing) and PSC Medical and Surgical Instruments, Equipment, and Supplies.

Bard's federal customer base is heavily concentrated in VA procurement. Defense Logistics Agency Troop Support Medical dominates by potential value ($54.1 million across 879 awards), but the Department of Veterans Affairs accounts for the plurality of named funding agencies. Within VA, multiple Veterans Integrated Service Networks (VISN 15, VISN 23, VISN 17, VISN 22, VISN 12, and VISN 9) each issue routine purchase orders for vascular stents and surgical implants in the $11,000 to $27,000 range. Recent representative prime awards include a July 2026 purchase order from VISN 15 for $17,085 in vascular stents, a June 2026 order from VISN 23 for $31,800 in pre-surgery supplies, and a November 2022 Defense Health Agency order for $132,821 in Phasix ST mesh. Bard also holds an indefinite delivery contract with the Department of the Army Medical Command for Arctic Sun gel pads supplied to Tripler Army Medical Center in Hawaii, valued at approximately $164,492 and running through September 2023.

Bard operates exclusively as a prime contractor; the source reflects zero subcontract awards. Activity has grown modestly in recent years (three awards in 2022 to twenty-one in 2024, declining to fourteen in 2025 and six year-to-date in 2026), and recompete exposure is minimal — only one award (combined potential value $17 thousand) completes within the next twenty-four months. The vendor's federal supply schedule footprint is substantial: Federal Supply Schedule V797P4971A carries 4,304 task orders valued at $12.1 million combined potential value, and Schedule V797P3357K carries 2,493 task orders valued at $2.7 million. An indefinite delivery contract (SPM2D011D0013) comprises 779 task orders and $2.7 million in combined potential value. Across all awards, the vendor has invoiced $48.7 million against $137.6 million in combined potential value (35% of ceiling obligated as of the source snapshot).

Bard competes in full and open procurement across its portfolio — no awards carry set-aside designations. The vendor's capability framing, grounded in award history, centers on routine medical device replenishment for VA and DoD healthcare facilities: vascular stents and covered stents dominate the award count, followed by surgical implants, mesh, catheters, and specialized equipment such as temperature management systems and prosthetics. Bard is one of eight named subsidiaries under parent Becton, Dickinson and Company; others include Bard Peripheral Vascular, Inc., Bard Access Systems, Inc., Davol Inc., and Senorx, Inc., each carrying capability signals in their names but not separately tracked in the source federal awards data.

Quick answers

Is C.r. Bard, Inc. registered in SAM.gov?

Yes. C.r. Bard, Inc.'s SAM.gov registration is active through August 14, 2027.

Which contract vehicles does C.r. Bard, Inc. hold?

C.r. Bard, Inc. holds a place on 1 federal contract vehicle: FSS-65-II-A.

How much has C.r. Bard, Inc. received in federal contracts?

Federal contracts obligated $243,797 to C.r. Bard, Inc. in fiscal year 2025 and $791,088 in fiscal years 2023 through 2027.

How does C.r. Bard, Inc. rank among federal contractors?

C.r. Bard, Inc.'s parent company, Becton, Dickinson and Co, ranked #6 in PSC J065, #8 in NAICS 339112 and #10 in NAICS 3391 in FY2025.

What is C.r. Bard, Inc.'s most recent federal award?

C.r. Bard, Inc.'s most recent federal contract award is Vascular stents (36C25526P0272), from Veterans Integrated Service Network 15 (VHA), on July 20, 2026.

On GovTribe

See C.r. Bard, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors